Development of new drugs that act through membrane receptors and involve an action of inverse agonism.

Recent patents on CNS drug discovery

Volumn 1, Issue 2, 2006, Pages 207-217

  Rodríguez Puertas, Rafael ^a   Barreda Gómez, Gabriel ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CELL SURFACE RECEPTOR; HISTAMINE RECEPTOR; MELANOCORTIN RECEPTOR;

ANIMAL; DRUG DESIGN; DRUG EFFECT; HUMAN; INVERSE AGONISM; PATENT; REVIEW;

ANIMALS; DRUG DESIGN; DRUG INVERSE AGONISM; HUMANS; PATENTS AS TOPIC; RECEPTORS, CELL SURFACE; RECEPTORS, GABA; RECEPTORS, HISTAMINE; RECEPTORS, MELANOCORTIN;

EID: 39049147589     PISSN: 15748898     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488906777452730     Document Type: Review

References (86)